Press Releases
September 30, 2020
TFF Pharmaceuticals Announces Results of Its 2020 Annual Meeting of Stockholders
TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film FreezingSeptember 24, 2020
TFF Pharmaceuticals Comments on Animal Studies in the Development of High Potency Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical TrialSeptember 15, 2020
TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1 Clinical Trial
TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020September 14, 2020
TFF Pharmaceuticals to Participate in Anti-fungal Webinar Presented by Maxim Group LLC on September 17th, 2020
TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceSeptember 10, 2020
TFF Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Fierce Pharma: Union, TFF team up to fight COVID-19 with inhaled tapeworm medAugust 25, 2020
Fierce Pharma: Union, TFF team up to fight COVID-19 with inhaled tapeworm med
Outsourcing-Pharma.com: TFF, Union Therapeutics join on potential COVID-19 treatmentAugust 24, 2020
Outsourcing-Pharma.com: TFF, Union Therapeutics join on potential COVID-19 treatment
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamideAugust 13, 2020
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for its Thin Film Freezing Technology in Combination with niclosamide
TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business ResultsAugust 13, 2020
TFF Pharmaceuticals Reports Second Quarter 2020 Financial and Business Results
Austin Statesman: Austin’s TFF Pharmaceuticals raises $25.9M with stock offeringAugust 11, 2020
Austin Statesman: Austin’s TFF Pharmaceuticals raises $25.9M with stock offering